Concepedia

David Chow

DC

16

Publications

1.3K

Citations

14

H-Index

1992

Active since

Affiliations

Amgen (United States)(Current)

University of British Columbia

Academia Sinica

National Defense Medical Center

David Chow is an author at Amgen (United States) specializing in medicine, biochemistry, and microbiology.

ORCID

Top concepts

Publications per year

1992–2020

16

Publications

16

Discovery of AMG 232, a Potent, Selective, and Orally Bioavailable MDM2–p53 Inhibitor in Clinical Development

Daqing Sun, Zhihong Li, Yosup Rew et al. · Journal of Medicinal Chemistry · 2014 · 290 citations · Full text

Pleiotrophin stimulates fibroblasts and endothelial and epithelial cells and is expressed in human cancer.

Wen‐Feng Fang, N. R. Hartmann, David Chow et al. · Journal of Biological Chemistry · 1992 · 216 citations · Full text

, , +18

Structure-Based Design of Novel Inhibitors of the MDM2–p53 Interaction

Yosup Rew, Daqing Sun, Felix González-López de Turiso et al. · Journal of Medicinal Chemistry · 2012 · 166 citations · Full text

Synthetic group A streptogramin antibiotics that overcome Vat resistance

Qi Li, J. Pellegrino, D. John Lee et al. · Nature · 2020 · 112 citations · Full text

, , +5

Selective and Potent Morpholinone Inhibitors of the MDM2–p53 Protein–Protein Interaction

Ana Z. González, John Eksterowicz, Michael D. Bartberger et al. · Journal of Medicinal Chemistry · 2014 · 83 citations · Full text

Rows per page

1–5 of 16